A comprehensive view of Health Canada. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Health Canada approves Apex Labs’ take home psilocybin clinical trial; study to evaluate efficacy, safety, tolerability of APEX-52, a microdose, oral synthetic psilocybin drug product to treat depression, anxiety in adults diagnosed with PTSD
Published:
January 19, 2023
by Canada Newswire
|
Health Canada grants Novavax’s COVID-19 vaccine booster expanded authorization for use in adults aged 18 and older
Published:
January 17, 2023
by Indian Pharma Industry: Policies
|
Health Canada recalls Siemens Healthcare's Epoc Blood Analysis System
Published:
January 16, 2023
by Contify Life Science News
|
Health Canada recalls Siemens Healthcare’s Magnetom Systems due to distance measurement values displayed in MRI images on third-party postprocessing systems can occasionally be incorrect
Published:
January 13, 2023
by Contify Life Science News
|
Siemens Healthcare Diagnostics recalls Immulite 2000 System Thyroglobulin Assay in Canada; functional sensitivity may not meet some instructions for use claims, immulite thyroglobulin control level one may list result outside of published ranges
Published:
January 12, 2023
by Contify Life Science News
|
Ask us about our Government & Public Policy market view
Trending Chart
Interactive chart with headline count